Suppr超能文献

慢性肾脏病晚期进入透析患者的非akalemia 与缺血性卒中的相关性。

Association of Dyskalemias with Ischemic Stroke in Advanced Chronic Kidney Disease Patients Transitioning to Dialysis.

机构信息

Institute for Health Outcomes and Policy, College of Graduate Health Sciences, University of Tennessee Health Science Center, Memphis, Tennessee, USA.

Division of Nephrology, Department of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee, USA.

出版信息

Am J Nephrol. 2021;52(7):539-547. doi: 10.1159/000516902. Epub 2021 Jul 21.

Abstract

INTRODUCTION

Hypo- and hyperkalemia are associated with a higher risk of ischemic stroke. However, this association has not been examined in an advanced chronic kidney disease (CKD) population.

METHODS

From among 102,477 US veterans transitioning to dialysis between 2007 and 2015, 21,357 patients with 2 pre-dialysis outpatient estimated glomerular filtration rates <30 mL/min/1.73 m2 90-365 days apart and at least 1 potassium (K) each in the baseline and follow-up period were identified. We separately examined the association of both baseline time-averaged K (chronic exposure) and time-updated K (acute exposure) treated as categorized (hypokalemia [K <3.5 mEq/L] and hyperkalemia [K >5.5 mEq/L] vs. referent [3.5-5.5 mEq/L]) and continuous exposure with time to the first ischemic stroke event prior to dialysis initiation using multivariable-adjusted Cox regression models.

RESULTS

A total of 2,638 (12.4%) ischemic stroke events (crude event rate 41.9 per 1,000 patient years; 95% confidence interval [CI] 40.4-43.6) over a median (Q1-Q3) follow-up time of 2.56 (1.59-3.89) years were observed. The baseline time-averaged K category of hypokalemia (adjusted hazard ratio [aHR], 95% CI: 1.35, 1.01-1.81) was marginally associated with a significantly higher risk of ischemic stroke. However, time-updated hyperkalemia was associated with a significantly lower risk of ischemic stroke (aHR, 95% CI: 0.82, 0.68-0.98). The exposure-outcome relationship remained consistent when using continuous K levels for both the exposures.

DISCUSSION/CONCLUSION: In patients with advanced CKD, hypokalemia (chronic exposure) was associated with a higher risk of ischemic stroke, whereas hyperkalemia (acute exposure) was associated with a lower risk of ischemic stroke. Further studies in this population are needed to explore the mechanisms underlying these associations.

摘要

简介

低钾血症和高钾血症与缺血性卒中风险增加相关。然而,这种关联尚未在晚期慢性肾脏病(CKD)人群中进行研究。

方法

在 2007 年至 2015 年间接受透析治疗的 102477 名美国退伍军人中,我们确定了 21357 名患者,这些患者在基线和随访期间,每 90-365 天分别有两次透析前门诊估算肾小球滤过率<30mL/min/1.73m2,且至少有一次血钾(K)值,并且基线时间平均 K(慢性暴露)和时间更新 K(急性暴露)分别作为分类(低钾血症[K <3.5mEq/L]和高钾血症[K >5.5mEq/L]与参考值[3.5-5.5mEq/L])和连续暴露与透析前开始时首次缺血性卒中事件的时间进行了评估,使用多变量调整的 Cox 回归模型。

结果

在中位(Q1-Q3)随访时间为 2.56(1.59-3.89)年期间,共观察到 2638 例(12.4%)缺血性卒中事件(粗事件率为 41.9/1000 患者年;95%置信区间[CI]为 40.4-43.6)。基线时间平均 K 值的低钾血症(校正后的危险比[HR],95%CI:1.35,1.01-1.81)与缺血性卒中风险显著增加相关,但时间更新的高钾血症与缺血性卒中风险显著降低相关(HR,95%CI:0.82,0.68-0.98)。当两种暴露均使用连续 K 水平时,暴露-结局关系仍然一致。

讨论/结论:在晚期 CKD 患者中,低钾血症(慢性暴露)与缺血性卒中风险增加相关,而高钾血症(急性暴露)与缺血性卒中风险降低相关。需要在该人群中进行进一步研究以探讨这些关联的机制。

相似文献

2
Association of dyskalemias with short-term health care utilization in patients with advanced CKD.
J Manag Care Spec Pharm. 2021 Oct;27(10):1403-1415. doi: 10.18553/jmcp.2021.27.10.1403.
4
Association between serum potassium levels and adverse outcomes in chronic kidney disease: the Fukushima CKD cohort study.
Clin Exp Nephrol. 2021 Apr;25(4):410-417. doi: 10.1007/s10157-020-02010-7. Epub 2021 Jan 7.
6
Serum Potassium, End-Stage Renal Disease and Mortality in Chronic Kidney Disease.
Am J Nephrol. 2015;41(6):456-63. doi: 10.1159/000437151. Epub 2015 Jul 25.
7
Association of hyperkalemia with clinical outcomes in advanced chronic kidney disease.
Nefrologia (Engl Ed). 2019 Sep-Oct;39(5):513-522. doi: 10.1016/j.nefro.2019.01.007. Epub 2019 Apr 23.
8
Association between Serum Potassium and Outcomes in Patients with Reduced Kidney Function.
Clin J Am Soc Nephrol. 2016 Jan 7;11(1):90-100. doi: 10.2215/CJN.01730215. Epub 2015 Oct 23.

本文引用的文献

2
Predialysis Potassium Variability and Postdialysis Mortality in Patients With Advanced CKD.
Kidney Int Rep. 2021 Jan 14;6(2):366-380. doi: 10.1016/j.ekir.2020.11.022. eCollection 2021 Feb.
3
Laxative Use and Risk of Dyskalemia in Patients with Advanced CKD Transitioning to Dialysis.
J Am Soc Nephrol. 2021 Apr;32(4):950-959. doi: 10.1681/ASN.2020081120. Epub 2021 Feb 5.
4
Does dietary potassium intake associate with hyperkalemia in patients with chronic kidney disease?
Nephrol Dial Transplant. 2021 Nov 9;36(11):2049-2057. doi: 10.1093/ndt/gfaa232.
5
Potassium Intake and Blood Pressure: A Dose-Response Meta-Analysis of Randomized Controlled Trials.
J Am Heart Assoc. 2020 Jun 16;9(12):e015719. doi: 10.1161/JAHA.119.015719. Epub 2020 Jun 5.
7
Physiology and Pathophysiology of Potassium Homeostasis: Core Curriculum 2019.
Am J Kidney Dis. 2019 Nov;74(5):682-695. doi: 10.1053/j.ajkd.2019.03.427. Epub 2019 Jun 19.
9
Statin Therapy Before Transition to End-Stage Renal Disease With Posttransition Outcomes.
J Am Heart Assoc. 2019 Mar 19;8(6):e011869. doi: 10.1161/JAHA.118.011869.
10
Elevated Serum Potassium Concentration Alleviates Cerebral Ischemia-Reperfusion Injury via Mitochondrial Preservation.
Cell Physiol Biochem. 2018;48(4):1664-1674. doi: 10.1159/000492289. Epub 2018 Aug 3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验